On Wednesday (December 17th), ELK (Wuhan) Biotechnology Co., Ltd. (hereinafter referred to as "ELK") warmly welcomed Mr. Edward Ye, Vice President of Level Biotechnology Inc. from Taiwan. During this meeting, the two parties had a fruitful discussion on the future model of in-depth cooperation, and based on their highly consistent development concepts, they successfully reached a cooperation agreement.

PART 01 Welcome Distinguished Guests, Revisit Cooperation Foundations

Level Biotechnology Inc. was established in 1989 and is a well-established and renowned enterprise in the field of biotechnology in Taiwan. Vice President Ye Jiaxian's special visit this time was warmly received by ELK CEO Mr. Xia and the team. The two sides felt like old friends gathering together, and in a warm and harmonious atmosphere, they began this exchange journey.

PART 02 On-site Visit to Experience Innovative Strength

Accompanied by ELK staff, Vice President Ye conducted a comprehensive visit to the company's laboratory spaces spanning the 4th to 11th floors. From the bright and efficient office areas on the 4th-5th floors, to the rigorous and orderly kit preparation and quality inspection area as well as ELISA laboratory on the 6th-7th floors, and further to the core R&D zone with five technology platforms and high-standard animal facility on the 8th-11th floors, Vice President Ye spoke highly of ELK's brand-new look, advanced hardware facilities, standardized production processes, and solid R&D capabilities. Particularly during the visit to the core technology platforms, ELK's professional accumulation and innovative achievements in biological reagents, antibodies, proteins, and molecular products left a deep impression on Vice President Ye.

PART 03: Consistent Philosophies, Jointly Mapping Cooperation Blueprint

After the visit, both parties moved to the meeting room for in-depth discussions. During the communication, ELK detailed its product matrix, technological advantages, Taiwan market channel cooperation strategies, and future expansion plans. Vice President Ye also shared Level Biotechnology Inc.'s long history, business layout, and industry experience. The two companies found that they share highly consistent philosophies in emphasizing product quality, adhering to technological innovation, and committing to serving scientific research and industrial development. Based on this, the talks focused on exploring models and paths for future in-depth cooperation, with pragmatic discussions on resource sharing, technological complementarity, and market synergy. In a friendly and efficient atmosphere, both parties successfully reached a cooperation intention and jointly envisioned broad prospects for mutual development.

Hand in Hand to Create a New Chapter for Cross-Strait Industry 

Vice President Ye's visit not only deepened mutual understanding and trust but also marked a new stage in the cooperation between ELK and Taiwan's Level Biotechnology Inc. ELK Biotechnology expresses its admiration for Level Biotechnology Inc.'s long-term dedication to the industry and is full of confidence in the future. Both parties agreed to take this opportunity to promote the integration of advantages and collaborative innovation in the cross-strait biotechnology industry, jointly contribute professional strength to scientific research progress and health undertakings, and write a new chapter of win-win cooperation.

After the meeting, a tasting of authentic Hubei cuisine was arranged. The client was accompanied to climb the Yellow Crane Tower to enjoy the thousand-year scenic views and watch the "Crane Dance in the Sky" performance. Through this immersive experience of the Chu culture, the friendship was further strengthened.